Your browser doesn't support javascript.
Influence of the first wave of COVID-19 on asthma inhaler prescriptions.
Bloom, C I; Wong, E; Hickman, K; Elkin, S.
  • Bloom CI; National Heart and Lung Institute, Imperial College London, Guy Scadding Building, Dovehouse Street, London, SW3 6LY, UK. Chloe.bloom06@imperial.ac.uk.
  • Wong E; Imperial College Healthcare NHS Trust and Imperial College London, NHLI, London, UK.
  • Hickman K; West Yorkshire & Harrogate Health and Care Partnership, Low Moor Medical Practice, Bradford, West Yorkshire, UK.
  • Elkin S; Imperial College Healthcare NHS Trust and Imperial College London, NHLI, London, UK.
NPJ Prim Care Respir Med ; 31(1): 45, 2021 11 25.
Article in English | MEDLINE | ID: covidwho-1537316
ABSTRACT
In the beginning of the COVID-19 pandemic, there were major concerns regarding the huge demand for asthma inhalers. Using the primary-care medical records for 614,700 asthma patients between January and June 2020, we found that there was a substantial increase in inhalers solely in March 2020. Patients significantly associated with receiving higher inhaled corticosteroid prescriptions were younger, of higher socioeconomic status, and had milder asthma.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Asthma / COVID-19 Limits: Humans Language: English Journal: NPJ Prim Care Respir Med Year: 2021 Document Type: Article Affiliation country: S41533-021-00260-w

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Asthma / COVID-19 Limits: Humans Language: English Journal: NPJ Prim Care Respir Med Year: 2021 Document Type: Article Affiliation country: S41533-021-00260-w